Brad Dajani, M.D.
Neurology Physician in Coral Springs, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 20,467 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Brad Dajani, M.D. reported a CMS MIPS final score of 76.2/100 - below the 83.5 national average - and filed 3,684 Medicare Part D claims in 2024.
- 76.2/100
- MIPS score · -7 vs avg
- 4K
- Part D claims, 2024
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Brad Dajani, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1659494854), first enumerated 04/10/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,684 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 76.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$10.1K in reported industry payments (355 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Brad Dajani, M.D.'s individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1659494854 · Neurology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1659494854
- ENUM-MID 2007
- TAX-MID 20K Neurology Physician
- MIPS-BELOW 76.2/100
- RX-MID 3,684
- BOOK-LIGHT 1,428 in Florida
- PHOTO-FINISH Channa Kolb · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Dajani · this pr…
Dajani · this provider
76.2 MIPS pts
- Mark Baron · hig…
Mark Baron
76.2 MIPS pts
- Channa Kolb · near
Channa Kolb
76.2 MIPS pts
- Karissa Arthur ·…
Karissa Arthur
76.2 MIPS pts
- Christine Baca ·…
Christine Baca
76.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Brad Dajani, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Brad Dajani, M.D. sits
This provider among neurology physician peers
Across the 5,099 neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Brad Dajani, M.D. writes more Part D claims than 89% of them and scores higher on MIPS quality than 20% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one neurology physician peer from a representative sample of 60; the gold marker is Brad Dajani, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Brad Dajani, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Brad Dajani, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Neurology Physician compares to other specialties among Florida providers
Neurology Physician ranks #58 among Florida's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Neurology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Brad Dajani, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average
- MIPS Final Score
- 76.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Neurology Physician US NPIs
76.2/100 MIPS final score - 7.3 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Neurology Physician. Quality dim: 62.7. Cost dim: 54.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1659494854 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/10/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Brad Dajani, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1659494854 is the unique 10-digit identifier CMS uses to link Dajani across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Brad Dajani, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Brad Dajani, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$10.1K
Largest payer
UCB, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Brad Dajani, M.D.. To verify Brad Dajani, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 3,684 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 7,451.367
- Total Day Supply
- 219,305
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $2.4M
- Generic Drug Cost
- $113K
- Opioid Claims
- 64 (1.7% rate)
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 2.04
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 82, 65-74: 222, 75-84: 203, 85+: 72
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Brad Dajani, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Memantine Hcl
Memantine Hcl
549 claims
- Gabapentin 206
Gabapentin
206 claims
- Donepezil Hcl 173
Donepezil Hcl
173 claims
- Carbidopa-Levodopa 166
Carbidopa-Levodopa
166 claims
- Levetiracetam 122
Levetiracetam
122 claims
- Primidone 105
Primidone
105 claims
- Alprazolam 98
Alprazolam
98 claims
- Folic Acid 90
Folic Acid
90 claims
| Drug | Claims |
|---|---|
| Memantine Hcl | 549 |
| Gabapentin | 206 |
| Donepezil Hcl | 173 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 166 |
| Levetiracetam | 122 |
| Primidone | 105 |
| Alprazolam | 98 |
| Folic Acid | 90 |
| Rivastigmine Rivastigmine Tartrate | 86 |
| Lacosamide | 69 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How Brad Dajani, M.D. fits within the Neurology Physician landscape nationally.
Brad Dajani, M.D.'s 3,684 claims are above the specialty average of 1,356.
Nationwide Neurology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Dajani, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (76.2 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Neurology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Dajani.
One of 1,428 Neurology Physician providers enrolled in Florida, 5 are shown here.
Compare Neurology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Brad Dajani, M.D.'s specialty? ▼
How much does Brad Dajani, M.D. prescribe under Medicare Part D? ▼
What is Brad Dajani, M.D.'s Medicare quality score? ▼
Where is Brad Dajani, M.D. located? ▼
What is Brad Dajani, M.D.'s NPI number? ▼
Does Brad Dajani, M.D. prescribe more brand-name or generic drugs? ▼
Does Brad Dajani, M.D. prescribe opioids? ▼
How many Neurology Physician providers are there in the US? ▼
What drugs does Brad Dajani, M.D. prescribe most often? ▼
Does Brad Dajani, M.D. accept Medicare? ▼
How can I verify Brad Dajani, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.